Yahoo Web Search

Search results

  1. 2 days ago · Prof. Özlem Türeci, M.D., Co-Founder and Chief Medical Officer of BioNTech, is a physician, immunologist, and cancer researcher with translational and clinical experience. Dr. Türeci has helped lead the discovery of cancer antigens, the development of mRNA-based individualized and off-the-shelf vaccine candidates and other types of ...

  2. 6 days ago · Özlem Türeci ha añadido que el premio galardona "el propósito más noble de la ciencia y la tecnología: servir a la Humanidad" y ha agradecido el apoyo a la investigación de la Unión Europea.

  3. 4 days ago · In her talk, Türeci will cover research on mRNA-based immunotherapies and how mRNA vaccines could be used to prevent and treat other chronic diseases, such as cancer. The discussion will be held online. Find more information and join the session here.

  4. 6 days ago · El Rey Felipe VI otorga el Premio Círculo de Economía a la Construcción Europea 2024 a Ugur Sahin y Özlem Türeci, los cofundadores de la biotecnológica BioNTech, que desarrolló la primera ...

  5. 5 days ago · El Círculo de Economía entrega su premio a la construcción europea a Uğur Şahin y Özlem Türeci, cofundadores de BioNtech. Los científicos lideraron la creación de la primera vacuna específica contra la Covid-19 durante la pandemia. El vaccí creado por los dos expertos alemanes fue posteriormente distribuido por Pfizer, y ocupó buena ...

  6. 5 days ago · "Our aim is to develop innovative treatment options across the continuum of cancer disease and establish new treatment paradigms that have the potential to address the fundamental challenges of treating cancer to drive meaningful improvements in the long-term survival rates for patients," said Prof. Özlem Türeci, M.D., Co-Founder and Chief ...

  7. 1 day ago · Uğur Şahin, 58, gründete mit seiner Frau Özlem Türeci das Biotechnologie-Unternehmen Biontech, das 2020 den Covid-19-Impfstoff Comirnaty entwickelte.

  1. People also search for